Financials of Torrent Pharmaceuticals Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Torrent Pharmaceuticals Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +2,4912,5912,6602,7322,7452,8592,8892,8092,9593,1783,3023,3034,197
Expenses +1,7641,8001,8351,8631,8621,9551,9501,8951,9952,1462,2192,2152,841
Operating Profit7277918258698839049399149641,0321,0831,0881,356
OPM %29%31%31%32%32%32%32%33%33%32%33%33%32%
Other Income +93426553124-1633-42-37-40-23-83
Interest10710391808075645756564845236
Depreciation196191201213203197198199201201204206508
Profit before tax433531559631631656661691665738791814529
Tax %34%29%31%30%29%30%31%27%25%26%25%22%31%
Net Profit +287378386443449457453503498548591635364
EPS in Rs8.4811.1711.4113.0913.2713.5013.3814.8614.7116.1917.4618.7610.76

Financials of Torrent Pharmaceuticals Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +4,6366,6875,8165,9507,6737,9398,0058,5089,62010,72811,51613,980
Expenses +3,6163,9544,4384,6015,6905,7695,5246,0776,7787,3607,7959,421
Operating Profit1,0202,7331,3771,3491,9832,1702,4802,4312,8423,3683,7214,559
OPM %22%41%24%23%26%27%31%29%30%31%32%33%
Other Income +28632223299-30012157-28845146-1-183
Interest175184206308504451353255333354252385
Depreciation1912383074096186546586627078087951,119
Profit before tax9402,3431,0889315621,1871,5261,2261,8472,3522,6732,872
Tax %20%26%14%27%22%14%18%37%33%30%28%26%
Net Profit +7511,7339346784361,0251,2527771,2451,6561,9112,138
EPS in Rs22.1951.2227.5920.0412.8930.2836.9922.9736.7948.9456.4763.17
Dividend Payout %25%34%25%35%66%53%47%105%60%57%57%0%

Financials of Torrent Pharmaceuticals Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital8585858585858585169169169169
Reserves2,4063,4094,2664,5384,6404,7395,7535,8686,0296,6877,4218,220
Borrowings +2,7402,3522,5106,4626,0385,7844,8744,0705,3694,0223,20215,025
Other Liabilities +2,5893,0402,7403,1593,3513,4023,3632,8843,0433,6273,60320,898
Total Liabilities7,8208,8869,60114,24314,11314,01014,07512,90614,61014,50514,39644,312
Fixed Assets +2,8332,8593,6887,8557,7487,5337,0656,4238,1218,1387,94733,376
CWIP6781,042519647617712889630765361478457
Investments2987808044923532181226199173156949
Other Assets +4,0114,2064,5895,2495,3955,7635,9405,6285,5245,8345,8159,530
Total Assets7,8208,8869,60114,24314,11314,01014,07512,90614,61014,50514,39644,312

Financials of Torrent Pharmaceuticals Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +8102,7421,0098941,7981,3932,0051,8032,3683,2662,5853,023
Cash from Investing Activity +-2,113-869-798-4,677-246229-444-196-2,335-160-549-12,713
Cash from Financing Activity +1,212-1,435-1933,417-1,314-1,549-1,651-1,78177-2,780-2,29810,151
Net Cash Flow-9043718-36623873-89-174110327-262461
Free Cash Flow5742,1505231051,1389901,6711,6071,9532,9671,9912,387
CFO/OP85%121%101%87%105%77%88%91%97%112%86%84%

Financials of Torrent Pharmaceuticals Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1257960776876697074635979
Inventory Days275314318429318362456368298310334338
Days Payable472523356447345345351250224284239254
Cash Conversion Cycle-71-1302159429317418814789154163
Working Capital Days29-128-80-62-52-57-33-277-3
ROCE %27%48%19%13%13%15%17%19%20%23%27%15%